Proto Labs (PRLB) Cash & Equivalents (2011 - 2026)

Proto Labs has disclosed Cash & Equivalents across 16 years of filings, most recently posting $124.0 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $124.0 million, up 49.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $124.0 million (up 49.92% YoY), and the FY2025 annual result was $110.8 million, up 24.42% from the prior year.
• Cash & Equivalents came in at $124.0 million for Q1 2026 at Proto Labs, up from $110.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $124.0 million in Q1 2026 to a low of $54.7 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $83.8 million (2023), against an average of $82.5 million.
• Across the five-year window, Cash & Equivalents dropped 14.21% in 2022 and soared 49.92% in 2026, its largest moves.
• Proto Labs' Cash & Equivalents stood at $56.6 million in 2022, then jumped by 48.15% to $83.8 million in 2023, then grew by 6.3% to $89.1 million in 2024, then gained by 24.42% to $110.8 million in 2025, then climbed by 11.86% to $124.0 million in 2026.
• The last three Cash & Equivalents figures came in at $124.0 million (Q1 2026), $110.8 million (Q4 2025), and $104.4 million (Q3 2025), per Business Quant data.